Hemophilia Vascular

Vascular hemophilia, also known as angiohemophilia, is a rare inherited disease that causes bleeding disorders. This condition is caused by a deficiency of clotting factor VIII, which plays a key role in the blood clotting process.

Vascular hemophilia is inherited in a recessive manner, which means that a person must inherit two copies of the gene responsible for this disease - one from each parent. However, men are more likely to suffer from vascular hemophilia than women, since the gene responsible for this disease is located on the X chromosome.

The main symptoms of vascular hemophilia are severe hemorrhages in joints, muscles and other tissues, as well as an increased tendency to bleed after injuries and operations. These symptoms can lead to the development of serious complications such as arthritis, joint deformities, bruises and bleeding inside the body.

Treatment for hemophilia vascular disease involves administering the clotting factor VIII as replacement therapy to prevent or stop bleeding. New treatments for hemophilia have now been developed, such as gene therapy, which may provide long-term protection against bleeding.

In conclusion, hemophilia vascularis is a serious inherited disease that causes bleeding disorders and can lead to serious complications. However, modern treatment methods make it possible to control this disease and prevent its complications, which allows patients to live a full life.